Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Saccades | 35 | 2016 | 233 | 5.910 |
Why?
|
Schizophrenia | 68 | 2024 | 6915 | 4.300 |
Why?
|
Psychomotor Performance | 25 | 2024 | 1878 | 2.710 |
Why?
|
Sleep | 27 | 2024 | 4750 | 2.240 |
Why?
|
Sleep Stages | 11 | 2024 | 691 | 2.140 |
Why?
|
Reaction Time | 32 | 2014 | 2075 | 1.890 |
Why?
|
Memory, Short-Term | 20 | 2022 | 978 | 1.790 |
Why?
|
Gyrus Cinguli | 10 | 2014 | 1114 | 1.640 |
Why?
|
Brain Mapping | 32 | 2024 | 6569 | 1.590 |
Why?
|
Schizophrenic Psychology | 19 | 2018 | 1646 | 1.340 |
Why?
|
Magnetoencephalography | 8 | 2014 | 634 | 1.270 |
Why?
|
Functional Laterality | 17 | 2018 | 2253 | 1.260 |
Why?
|
Nerve Net | 15 | 2019 | 2261 | 1.250 |
Why?
|
Cerebral Cortex | 14 | 2024 | 5761 | 1.160 |
Why?
|
Memory | 11 | 2024 | 2179 | 1.110 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2014 | 275 | 1.090 |
Why?
|
Polysomnography | 9 | 2022 | 1825 | 1.050 |
Why?
|
Electroencephalography | 22 | 2024 | 6189 | 1.020 |
Why?
|
Attention | 13 | 2022 | 2387 | 0.990 |
Why?
|
Thalamus | 8 | 2024 | 1041 | 0.930 |
Why?
|
Magnetic Resonance Imaging | 62 | 2024 | 36286 | 0.900 |
Why?
|
Neural Pathways | 13 | 2022 | 3040 | 0.890 |
Why?
|
Prefrontal Cortex | 15 | 2016 | 2212 | 0.880 |
Why?
|
Brain | 34 | 2024 | 26951 | 0.880 |
Why?
|
Photic Stimulation | 17 | 2013 | 1967 | 0.800 |
Why?
|
Brain Waves | 4 | 2019 | 401 | 0.780 |
Why?
|
Child Development Disorders, Pervasive | 4 | 2014 | 599 | 0.780 |
Why?
|
Mental Processes | 3 | 2016 | 245 | 0.760 |
Why?
|
Executive Function | 4 | 2016 | 1374 | 0.750 |
Why?
|
Pattern Recognition, Visual | 5 | 2012 | 810 | 0.650 |
Why?
|
Frontal Lobe | 7 | 2016 | 1420 | 0.650 |
Why?
|
Thalamic Nuclei | 1 | 2019 | 111 | 0.630 |
Why?
|
Body Dysmorphic Disorders | 1 | 2022 | 243 | 0.620 |
Why?
|
Dominance, Cerebral | 4 | 2007 | 622 | 0.610 |
Why?
|
Cognition Disorders | 11 | 2017 | 3976 | 0.550 |
Why?
|
Aquatic Organisms | 1 | 2016 | 42 | 0.530 |
Why?
|
Orientation | 3 | 2007 | 321 | 0.520 |
Why?
|
Birds | 1 | 2016 | 168 | 0.510 |
Why?
|
Learning | 5 | 2022 | 1739 | 0.500 |
Why?
|
Adult | 96 | 2024 | 220007 | 0.490 |
Why?
|
Autistic Disorder | 6 | 2022 | 1214 | 0.490 |
Why?
|
Neuropsychological Tests | 27 | 2017 | 7022 | 0.490 |
Why?
|
Endophenotypes | 2 | 2017 | 255 | 0.480 |
Why?
|
Feedback, Psychological | 3 | 2011 | 95 | 0.470 |
Why?
|
Visual Fields | 3 | 2014 | 1054 | 0.460 |
Why?
|
Cognition | 13 | 2023 | 6964 | 0.450 |
Why?
|
Video Games | 1 | 2016 | 190 | 0.440 |
Why?
|
Azabicyclo Compounds | 1 | 2013 | 68 | 0.440 |
Why?
|
Male | 103 | 2024 | 359718 | 0.420 |
Why?
|
Humans | 134 | 2024 | 760613 | 0.390 |
Why?
|
Obsessive-Compulsive Disorder | 3 | 2018 | 1489 | 0.390 |
Why?
|
Female | 99 | 2024 | 391246 | 0.380 |
Why?
|
Evoked Potentials | 2 | 2014 | 1036 | 0.360 |
Why?
|
Volition | 2 | 2010 | 62 | 0.360 |
Why?
|
Diffusion Magnetic Resonance Imaging | 7 | 2018 | 2782 | 0.360 |
Why?
|
Mammals | 1 | 2016 | 1131 | 0.360 |
Why?
|
Hypnotics and Sedatives | 2 | 2020 | 1178 | 0.360 |
Why?
|
Catechol O-Methyltransferase | 2 | 2009 | 251 | 0.350 |
Why?
|
Intention | 1 | 2013 | 345 | 0.340 |
Why?
|
Image Processing, Computer-Assisted | 16 | 2017 | 8950 | 0.320 |
Why?
|
Asperger Syndrome | 3 | 2005 | 56 | 0.310 |
Why?
|
Cerebrum | 1 | 2010 | 132 | 0.310 |
Why?
|
Behavior | 1 | 2011 | 540 | 0.310 |
Why?
|
Motor Cortex | 2 | 2014 | 995 | 0.310 |
Why?
|
Stereotyped Behavior | 1 | 2008 | 135 | 0.300 |
Why?
|
Young Adult | 30 | 2024 | 58748 | 0.300 |
Why?
|
Motor Skills | 3 | 2024 | 520 | 0.290 |
Why?
|
Memory Disorders | 6 | 2015 | 1197 | 0.290 |
Why?
|
Neural Conduction | 1 | 2008 | 441 | 0.280 |
Why?
|
Fixation, Ocular | 1 | 2007 | 240 | 0.260 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2015 | 1079 | 0.260 |
Why?
|
Middle Aged | 53 | 2024 | 220359 | 0.260 |
Why?
|
Evoked Potentials, Motor | 2 | 2008 | 461 | 0.250 |
Why?
|
Thinking | 3 | 2016 | 319 | 0.250 |
Why?
|
Form Perception | 2 | 2004 | 175 | 0.250 |
Why?
|
Motor Activity | 2 | 2018 | 2688 | 0.250 |
Why?
|
Perceptual Disorders | 1 | 2007 | 197 | 0.250 |
Why?
|
Analysis of Variance | 10 | 2014 | 6238 | 0.240 |
Why?
|
Social Perception | 3 | 2009 | 431 | 0.240 |
Why?
|
Mental Recall | 2 | 2015 | 1206 | 0.240 |
Why?
|
Hippocampus | 3 | 2024 | 3738 | 0.230 |
Why?
|
Wakefulness | 4 | 2022 | 1255 | 0.230 |
Why?
|
Choice Behavior | 2 | 2011 | 821 | 0.230 |
Why?
|
Genetic Predisposition to Disease | 8 | 2022 | 17790 | 0.230 |
Why?
|
Face | 2 | 2007 | 1017 | 0.230 |
Why?
|
Prosopagnosia | 1 | 2004 | 64 | 0.220 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2012 | 952 | 0.220 |
Why?
|
Dyslexia | 2 | 2022 | 210 | 0.220 |
Why?
|
Parietal Lobe | 2 | 2010 | 850 | 0.210 |
Why?
|
Piperazines | 1 | 2013 | 2525 | 0.210 |
Why?
|
Reference Values | 6 | 2012 | 4925 | 0.200 |
Why?
|
Amnesia | 1 | 2024 | 255 | 0.200 |
Why?
|
Amygdala | 2 | 2009 | 1351 | 0.200 |
Why?
|
Visual Cortex | 2 | 2007 | 1089 | 0.200 |
Why?
|
Affective Symptoms | 1 | 2004 | 416 | 0.200 |
Why?
|
Visual Perception | 3 | 2018 | 1374 | 0.190 |
Why?
|
Antipsychotic Agents | 10 | 2017 | 3061 | 0.190 |
Why?
|
Epilepsy, Rolandic | 1 | 2022 | 54 | 0.190 |
Why?
|
Occipital Lobe | 1 | 2022 | 373 | 0.190 |
Why?
|
Task Performance and Analysis | 6 | 2016 | 759 | 0.180 |
Why?
|
Space Perception | 1 | 2004 | 464 | 0.180 |
Why?
|
Diazepam | 1 | 2021 | 215 | 0.180 |
Why?
|
Models, Neurological | 5 | 2011 | 1758 | 0.180 |
Why?
|
Acoustic Stimulation | 2 | 2023 | 1232 | 0.180 |
Why?
|
Ataxia | 1 | 2022 | 305 | 0.170 |
Why?
|
Eye Movement Measurements | 2 | 2010 | 31 | 0.170 |
Why?
|
Epilepsy, Generalized | 1 | 2022 | 178 | 0.170 |
Why?
|
Leukoencephalopathies | 2 | 2012 | 249 | 0.160 |
Why?
|
Fingers | 2 | 2014 | 506 | 0.160 |
Why?
|
Social Behavior | 2 | 2005 | 1131 | 0.160 |
Why?
|
Adolescent | 24 | 2024 | 87809 | 0.160 |
Why?
|
Cues | 5 | 2015 | 867 | 0.160 |
Why?
|
Case-Control Studies | 9 | 2019 | 22052 | 0.160 |
Why?
|
Alleles | 4 | 2014 | 6900 | 0.150 |
Why?
|
Neural Inhibition | 1 | 2002 | 589 | 0.150 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4286 | 0.150 |
Why?
|
Anisotropy | 3 | 2012 | 1278 | 0.150 |
Why?
|
Cross-Over Studies | 2 | 2020 | 2061 | 0.150 |
Why?
|
Child | 13 | 2023 | 79799 | 0.150 |
Why?
|
Basal Ganglia | 1 | 2000 | 552 | 0.140 |
Why?
|
DNA Methylation | 1 | 2011 | 4372 | 0.140 |
Why?
|
Double-Blind Method | 5 | 2020 | 12427 | 0.140 |
Why?
|
Epilepsies, Partial | 1 | 2021 | 430 | 0.140 |
Why?
|
Tetrahydrofolates | 1 | 2017 | 58 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 2 | 2007 | 4046 | 0.140 |
Why?
|
Amobarbital | 1 | 1996 | 43 | 0.130 |
Why?
|
Rest | 3 | 2018 | 914 | 0.130 |
Why?
|
Dexmedetomidine | 1 | 2020 | 316 | 0.130 |
Why?
|
GABA Modulators | 1 | 1996 | 109 | 0.130 |
Why?
|
Dopamine | 2 | 2016 | 1595 | 0.130 |
Why?
|
Regression Analysis | 3 | 2013 | 6359 | 0.130 |
Why?
|
Anticipation, Psychological | 1 | 2016 | 85 | 0.130 |
Why?
|
Genotype | 5 | 2017 | 12957 | 0.120 |
Why?
|
Psychiatric Status Rating Scales | 11 | 2017 | 6015 | 0.120 |
Why?
|
Oxygen | 7 | 2013 | 4193 | 0.120 |
Why?
|
Models, Psychological | 2 | 2011 | 827 | 0.120 |
Why?
|
Receptors, Dopamine D1 | 1 | 2016 | 293 | 0.120 |
Why?
|
Ocular Motility Disorders | 2 | 2007 | 143 | 0.120 |
Why?
|
Brain Diseases | 2 | 2021 | 1540 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2017 | 15790 | 0.120 |
Why?
|
Schizophrenic Language | 1 | 1994 | 57 | 0.120 |
Why?
|
Neurogranin | 1 | 2013 | 15 | 0.110 |
Why?
|
Receptors, Dopamine D4 | 1 | 2014 | 170 | 0.110 |
Why?
|
Intelligence | 2 | 2016 | 919 | 0.110 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2012 | 3340 | 0.110 |
Why?
|
Time Factors | 6 | 2011 | 40139 | 0.100 |
Why?
|
Neurophysiology | 2 | 2024 | 144 | 0.100 |
Why?
|
Algorithms | 4 | 2010 | 13982 | 0.100 |
Why?
|
Cycloserine | 3 | 1999 | 118 | 0.100 |
Why?
|
Anxiety | 2 | 2024 | 4538 | 0.090 |
Why?
|
Discrimination Learning | 3 | 2005 | 278 | 0.090 |
Why?
|
Punishment | 1 | 2011 | 95 | 0.090 |
Why?
|
Electrooculography | 1 | 2010 | 113 | 0.090 |
Why?
|
Signal Transduction | 2 | 2016 | 23374 | 0.090 |
Why?
|
Verbal Learning | 1 | 2012 | 462 | 0.090 |
Why?
|
Temporal Lobe | 4 | 2012 | 1688 | 0.090 |
Why?
|
Neostriatum | 1 | 2011 | 246 | 0.090 |
Why?
|
Electrophysiological Phenomena | 1 | 2011 | 309 | 0.080 |
Why?
|
Kinesics | 1 | 2009 | 13 | 0.080 |
Why?
|
Knowledge | 1 | 2010 | 176 | 0.080 |
Why?
|
Reproducibility of Results | 7 | 2016 | 20080 | 0.080 |
Why?
|
Substantia Nigra | 1 | 2011 | 350 | 0.080 |
Why?
|
Corpus Striatum | 2 | 2016 | 1233 | 0.080 |
Why?
|
Genome-Wide Association Study | 4 | 2016 | 12628 | 0.080 |
Why?
|
Parkinson Disease | 1 | 2002 | 2859 | 0.080 |
Why?
|
Expressed Emotion | 1 | 2009 | 92 | 0.080 |
Why?
|
Aging | 2 | 2018 | 8652 | 0.080 |
Why?
|
Severity of Illness Index | 6 | 2014 | 15840 | 0.070 |
Why?
|
Random Allocation | 2 | 2002 | 2394 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3701 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2021 | 3193 | 0.070 |
Why?
|
Psychomotor Disorders | 1 | 2007 | 149 | 0.070 |
Why?
|
Emotions | 3 | 2024 | 2734 | 0.070 |
Why?
|
Tobacco Use Disorder | 1 | 2012 | 700 | 0.070 |
Why?
|
Social Behavior Disorders | 1 | 2005 | 96 | 0.060 |
Why?
|
Actigraphy | 1 | 2009 | 518 | 0.060 |
Why?
|
Eye Movements | 1 | 2008 | 508 | 0.060 |
Why?
|
Information Dissemination | 1 | 2013 | 1131 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 2 | 2012 | 2385 | 0.060 |
Why?
|
Magnetics | 2 | 2005 | 600 | 0.060 |
Why?
|
Reward | 1 | 2011 | 963 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 1988 | 0.060 |
Why?
|
Bipolar Disorder | 2 | 2019 | 5078 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2010 | 994 | 0.060 |
Why?
|
Principal Component Analysis | 3 | 2012 | 939 | 0.060 |
Why?
|
Linear Models | 3 | 2016 | 5877 | 0.050 |
Why?
|
Animals | 4 | 2020 | 167960 | 0.050 |
Why?
|
Statistics as Topic | 1 | 2009 | 2362 | 0.050 |
Why?
|
Linguistics | 1 | 2022 | 106 | 0.050 |
Why?
|
Observer Variation | 2 | 2005 | 2601 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2007 | 15286 | 0.050 |
Why?
|
Levodopa | 1 | 2002 | 217 | 0.050 |
Why?
|
Antiparkinson Agents | 1 | 2002 | 183 | 0.050 |
Why?
|
Motivation | 1 | 2011 | 1993 | 0.050 |
Why?
|
Language Development | 1 | 2022 | 181 | 0.050 |
Why?
|
Hemodynamics | 1 | 2011 | 4173 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12159 | 0.050 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2000 | 109 | 0.040 |
Why?
|
Facial Expression | 1 | 2004 | 508 | 0.040 |
Why?
|
Auditory Perception | 2 | 2018 | 580 | 0.040 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1121 | 0.040 |
Why?
|
Fear | 1 | 2009 | 1462 | 0.040 |
Why?
|
Schizotypal Personality Disorder | 1 | 2000 | 290 | 0.040 |
Why?
|
Probability Learning | 1 | 2018 | 23 | 0.040 |
Why?
|
Affective Disorders, Psychotic | 1 | 2019 | 186 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2004 | 2698 | 0.040 |
Why?
|
Developmental Disabilities | 1 | 2005 | 1504 | 0.030 |
Why?
|
Injections, Intra-Arterial | 1 | 1996 | 182 | 0.030 |
Why?
|
Kinetics | 1 | 2003 | 6377 | 0.030 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 1995 | 143 | 0.030 |
Why?
|
Time | 1 | 1997 | 545 | 0.030 |
Why?
|
Smoking | 1 | 2012 | 9073 | 0.030 |
Why?
|
Infant | 2 | 2023 | 36053 | 0.030 |
Why?
|
Biological Clocks | 1 | 2016 | 316 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2022 | 2013 | 0.030 |
Why?
|
Child, Preschool | 3 | 2023 | 42056 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2003 | 2733 | 0.030 |
Why?
|
Clozapine | 1 | 1996 | 506 | 0.030 |
Why?
|
Aged | 7 | 2024 | 169143 | 0.030 |
Why?
|
Concept Formation | 1 | 1994 | 159 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 4035 | 0.030 |
Why?
|
New Mexico | 1 | 2012 | 83 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2014 | 453 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2017 | 2852 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2014 | 494 | 0.020 |
Why?
|
Minnesota | 1 | 2012 | 340 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 25941 | 0.020 |
Why?
|
Problem Solving | 1 | 1994 | 440 | 0.020 |
Why?
|
Cohort Studies | 3 | 2024 | 41337 | 0.020 |
Why?
|
Syndrome | 1 | 1997 | 3280 | 0.020 |
Why?
|
Dreams | 1 | 1991 | 146 | 0.020 |
Why?
|
Folic Acid | 1 | 2017 | 1309 | 0.020 |
Why?
|
Models, Statistical | 1 | 2004 | 5075 | 0.020 |
Why?
|
Paralysis | 1 | 1991 | 251 | 0.020 |
Why?
|
Discriminant Analysis | 1 | 2009 | 223 | 0.020 |
Why?
|
Cerebral Ventricles | 1 | 2012 | 543 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2014 | 1376 | 0.020 |
Why?
|
Seizures | 1 | 2022 | 2917 | 0.020 |
Why?
|
Epilepsy | 1 | 2024 | 3267 | 0.020 |
Why?
|
Homozygote | 1 | 2013 | 1788 | 0.020 |
Why?
|
Hallucinations | 1 | 1991 | 366 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6180 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14661 | 0.020 |
Why?
|
Sleep, REM | 1 | 1991 | 593 | 0.020 |
Why?
|
Corpus Callosum | 1 | 2012 | 749 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 3 | 1999 | 893 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1500 | 0.020 |
Why?
|
Brain Stem | 1 | 2012 | 857 | 0.020 |
Why?
|
Goals | 1 | 2011 | 708 | 0.020 |
Why?
|
Nonverbal Communication | 1 | 2005 | 63 | 0.020 |
Why?
|
Communication Disorders | 1 | 2005 | 50 | 0.020 |
Why?
|
Reading | 1 | 2008 | 530 | 0.020 |
Why?
|
Drug Administration Schedule | 3 | 1999 | 4899 | 0.020 |
Why?
|
Cerebellum | 1 | 2012 | 1495 | 0.010 |
Why?
|
Self Report | 1 | 2016 | 3711 | 0.010 |
Why?
|
Chronic Disease | 2 | 2009 | 9288 | 0.010 |
Why?
|
Fourier Analysis | 1 | 2004 | 439 | 0.010 |
Why?
|
Placebos | 2 | 1999 | 1668 | 0.010 |
Why?
|
Genetic Testing | 1 | 2016 | 3531 | 0.010 |
Why?
|
Drug Therapy, Combination | 3 | 1999 | 6498 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2716 | 0.010 |
Why?
|
Demography | 1 | 2007 | 1650 | 0.010 |
Why?
|
Psychometrics | 1 | 2011 | 3051 | 0.010 |
Why?
|
Amino Acids | 2 | 1999 | 1714 | 0.010 |
Why?
|
Empathy | 1 | 2005 | 473 | 0.010 |
Why?
|
Sensory Thresholds | 1 | 2002 | 377 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14494 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7587 | 0.010 |
Why?
|
Genetic Variation | 1 | 2016 | 6552 | 0.010 |
Why?
|
United States | 1 | 2008 | 72448 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6465 | 0.010 |
Why?
|
Image Enhancement | 1 | 2010 | 2881 | 0.010 |
Why?
|
Treatment Outcome | 4 | 2017 | 64981 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 74333 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29957 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2004 | 1535 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2002 | 1735 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9468 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18413 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16548 | 0.010 |
Why?
|
Glycine | 1 | 1999 | 662 | 0.010 |
Why?
|
Movement | 1 | 2002 | 1474 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2008 | 7805 | 0.010 |
Why?
|
Nootropic Agents | 1 | 1995 | 157 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39262 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1996 | 10826 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 1991 | 4555 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13505 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 58980 | 0.010 |
Why?
|
Veterans | 1 | 2000 | 2642 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1996 | 2782 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2013 | 80345 | 0.000 |
Why?
|